In particular uPA, uPAR and the plasminogen activator inhibitor type-1 (PAI-1) are not only strongly upregulated in a wide variety of cancer types but their biological levels correlate with a poor neoplastic outcome and a more rapid tumor progression [22,43]. The gene discussed is PLAUR; the disease is cancer.